OncoTargets and Therapy
Volume 10, 2017 - Issue
Open access
45
Views
4
CrossRef citations to date
0
Altmetric
Original Research
Sequential treatment of tyrosine kinase inhibitor and platinum-based doublet chemotherapy on EGFR mutant non-small cell lung cancer: a meta-analysis of randomized controlled clinical trials
Lifen Qiao1 Department of Geriatrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China;2 Cancer Center, Medical College of Wisconsin, Milwaukee, WI, USA
, Jin Wang2 Cancer Center, Medical College of Wisconsin, Milwaukee, WI, USA;3 Department of Emergency
, Guoxian Long2 Cancer Center, Medical College of Wisconsin, Milwaukee, WI, USA;4 Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
& Yueqiang Jiang1 Department of Geriatrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China;5 Department of Toxicology and Pharmacology, Medical College of Wisconsin, Milwaukee, WI, USACorrespondence[email protected]
Pages 1279-1284
|
Published online: 28 Feb 2017
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.